生殖遺伝市場- 世界の産業規模、シェア、動向、機会、予測、コンポーネント別、技術別、手技タイプ別、用途別、地域別セグメント、競合、2020年～2030年

生殖遺伝の世界市場規模は2024年に58億7,000万米ドル、予測期間中のCAGRは13.52%で2030年には125億6,000万米ドルに達すると予測されています。

生殖遺伝の世界市場は、新興開発諸国における遺伝子工学に対する意識の高まりにより、より良くなるために大きな成長を遂げています。さらに、医療検査に対する償還の改善や、新たな診断センターを開発するための政府組織による複数の投資と並行して、生殖遺伝の需要が世界各地で大幅に増加しています。さらに、安全な生活を送るための様々な年齢層の女性の意識の高まりとともに、高度な検査の著しい成長が生殖遺伝の需要をさらに増加させ、市場の成長を加速させると予想されています。

市場促進要因

遺伝性疾患および不妊症の発生率の増加

主な市場課題

遺伝子検査を取り巻く倫理的・法的問題

主要市場動向

非侵襲的出生前検査（NIPT）への需要の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の生殖遺伝市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • コンポーネント別（ラボ開発検査、キットおよびアッセイ、試薬および消耗品）
  • 技術別（次世代シーケンシング、ポリメラーゼ連鎖反応、in situハイブリダイゼーション、マイクロアレイ）
  • 手技タイプ別（保因者スクリーニング、出生前スクリーニング、着床前遺伝子検査、不妊遺伝子検査）
  • 用途別（異数性、単一遺伝子疾患、染色体構造異常、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • コンポーネント別
  • 技術別
  • 手技タイプ別
  • 用途別
  • 地域別

第6章 北米の生殖遺伝市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の生殖遺伝市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の生殖遺伝市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の生殖遺伝市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの生殖遺伝市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威/サービス

第14章 世界の生殖遺伝市場：SWOT分析

第15章 競合情勢

• CooperSurgical, Inc.
• Centogene AG
• Invitae Corporation
• Illumina, Inc.
• Myriad Genetics, Inc.
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Natera, Inc
• Eurofins Scientific SE

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Reproductive Genetics Market was valued at USD 5.87 billion in 2024 and is expected to reach USD 12.56 billion by 2030 with a CAGR of 13.52% during the forecast period. The global market for Reproductive Genetics is experiencing significant growth, driven by the growing awareness towards genetic engineering in the developing countries, to get better. Additionally, growing reimbursement improvements for medical tests and initiative, running parallel to multiple investments by government organizations for developing new diagnostic centers, have significantly increased the demand for reproductive genetics across different parts of the globe. Additionally, significant growth in advanced testing along with increasing awareness among different age group women for leading safe life, are further expected to increase the demand for reproductive genetics, thereby fuelling the market growth.

Key Market Drivers

Increasing Incidence of Genetic Disorders and Infertility

One of the primary growth drivers for the reproductive genetics market is the rising incidence of genetic disorders and infertility worldwide. According to the World Health Organization (WHO), approximately 10% to 15% of couples globally experience infertility, and the number is rising due to changing lifestyles, environmental factors, and delayed family planning. At the same time, the prevalence of heritable genetic conditions such as Down syndrome, cystic fibrosis, and thalassemia has heightened the demand for early detection and diagnosis through genetic testing.

Reproductive genetic testing methods, such as preimplantation genetic testing (PGT), carrier screening, and non-invasive prenatal testing (NIPT), help assess genetic risks in embryos and fetuses, allowing couples to make informed reproductive decisions. For instance, the Centers for Disease Control and Prevention (CDC) has reported that the number of assisted reproductive technology (ART) cycles performed in the United States has grown steadily, reaching nearly 330,000 cycles in 2021. Many of these ART cycles now integrate reproductive genetic tests to ensure healthy pregnancies.

Governments across Europe and Asia are also promoting national screening programs for conditions such as thalassemia and Tay-Sachs disease, particularly in high-prevalence regions. Such public health initiatives have further solidified the role of genetic diagnostics in reproductive health. Consequently, as the burden of infertility and inherited disorders continues to rise, reproductive genetic testing is becoming a critical part of reproductive healthcare globally.

Key Market Challenges

Ethical and Legal Concerns Surrounding Genetic Testing

One of the most pressing challenges facing the reproductive genetics market is the complex web of ethical and legal issues. Genetic testing, especially in the context of reproduction, raises serious concerns related to privacy, consent, genetic discrimination, and the potential for "designer babies." The ethical dilemma is particularly pronounced in prenatal and preimplantation genetic testing, where the ability to select embryos based on genetic characteristics has sparked debates about eugenics and social equity. Laws vary widely across countries. For example, Germany strictly regulates embryo selection, while the United States offers broader flexibility, often guided by private clinics' policies.

There is also concern about data protection. Genetic information is highly sensitive, and breaches can lead to discrimination in insurance and employment. While regulations like the Genetic Information Nondiscrimination Act (GINA) in the U.S. provide some protection, gaps still exist in areas such as long-term care insurance. Moreover, reproductive genetic testing may disproportionately benefit higher-income groups, exacerbating healthcare disparities. In countries without universal healthcare, the high cost of these tests may place them out of reach for many, even though government-supported initiatives are increasing access.

Key Market Trends

Rising Demand for Non-Invasive Prenatal Testing (NIPT)

A major trend reshaping the global reproductive genetics landscape is the increasing adoption of non-invasive prenatal testing (NIPT). This technique analyzes cell-free fetal DNA circulating in maternal blood to detect chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18, and trisomy 13 as early as the 10th week of pregnancy. NIPT has gained rapid clinical acceptance due to its safety (as it avoids amniocentesis or chorionic villus sampling), high sensitivity, and low false-positive rates. According to the American College of Obstetricians and Gynecologists (ACOG), NIPT is now recommended for all pregnant women regardless of age or risk level. This policy shift has dramatically expanded the target patient population.

Globally, many countries have integrated NIPT into public health strategies. For instance, in 2021, the Netherlands became one of the first countries to fully reimburse NIPT as part of routine prenatal screening. Similar policies are being adopted in Canada, Germany, and parts of Asia, including China and Japan. Furthermore, technological innovations such as single-molecule sequencing and machine learning-based analysis platforms are making NIPT more accurate and cost-effective. With a growing number of pregnancies being managed with NIPT, this trend is expected to substantially boost demand for reproductive genetic services over the next decade.

Key Market Players

• CooperSurgical, Inc.
• Centogene AG
• Invitae Corporation
• Illumina, Inc.
• Myriad Genetics, Inc.
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Natera, Inc
• Eurofins Scientific SE

Report Scope:

In this report, the Global Reproductive Genetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Reproductive Genetics Market, By Component:

• Laboratory Developed Tests
• Kits & Assays
• Reagents & Consumables

Reproductive Genetics Market, By Technology:

• Next Generation Sequencing
• Polymerase Chain Reaction
• In Situ Hybridization
• Microarrays

Reproductive Genetics Market, By Procedure Type:

• Carrier Screening
• Prenatal Screening
• Preimplantation Genetic Testing
• Infertility Genetic Testing

Reproductive Genetics Market, By Application:

• Aneuploidy
• Single Gene Disorder
• Structural Chromosomal Abnormality
• Others

Reproductive Genetics Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Reproductive Genetics Market.

Available Customizations:

Global Reproductive Genetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Reproductive Genetics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables)
  • 5.2.2. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays)
  • 5.2.3. By Procedure Type (Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, Infertility Genetic Testing)
  • 5.2.4. By Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Component
  • 5.3.2. By Technology
  • 5.3.3. By Procedure Type
  • 5.3.4. By Application
  • 5.3.5. By Region

6. North America Reproductive Genetics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Technology
  • 6.2.3. By Procedure Type
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Reproductive Genetics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Procedure Type
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Reproductive Genetics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Procedure Type
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Reproductive Genetics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Procedure Type
      • 6.3.3.2.4. By Application

7. Europe Reproductive Genetics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Technology
  • 7.2.3. By Procedure Type
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Reproductive Genetics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Procedure Type
      • 7.3.1.2.4. By Application
  • 7.3.2. Germany Reproductive Genetics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Procedure Type
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Reproductive Genetics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Procedure Type
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Reproductive Genetics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Procedure Type
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Reproductive Genetics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Procedure Type
      • 7.3.5.2.4. By Application

8. Asia-Pacific Reproductive Genetics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Technology
  • 8.2.3. By Procedure Type
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Reproductive Genetics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Procedure Type
      • 8.3.1.2.4. By Application
  • 8.3.2. India Reproductive Genetics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Procedure Type
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Reproductive Genetics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Procedure Type
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Reproductive Genetics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Procedure Type
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Reproductive Genetics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Procedure Type
      • 8.3.5.2.4. By Application

9. South America Reproductive Genetics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Technology
  • 9.2.3. By Procedure Type
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Reproductive Genetics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Procedure Type
      • 9.3.1.2.4. By Application
  • 9.3.2. Argentina Reproductive Genetics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Procedure Type
      • 9.3.2.2.4. By Application
  • 9.3.3. Colombia Reproductive Genetics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Procedure Type
      • 9.3.3.2.4. By Application

10. Middle East and Africa Reproductive Genetics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Technology
  • 10.2.3. By Procedure Type
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Reproductive Genetics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Procedure Type
      • 10.3.1.2.4. By Application
  • 10.3.2. Saudi Arabia Reproductive Genetics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Procedure Type
      • 10.3.2.2.4. By Application
  • 10.3.3. UAE Reproductive Genetics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Procedure Type
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Reproductive Genetics Market: SWOT Analysis

15. Competitive Landscape

• 15.1. CooperSurgical, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Centogene AG
• 15.3. Invitae Corporation
• 15.4. Illumina, Inc.
• 15.5. Myriad Genetics, Inc.
• 15.6. Thermo Fisher Scientific Inc.
• 15.7. Laboratory Corporation of America Holdings
• 15.8. Quest Diagnostics
• 15.9. Natera, Inc
• 15.10. Eurofins Scientific SE

16. Strategic Recommendations

17. About Us & Disclaimer